Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices 73075 

1 79 FR 54276. 

2 In particular, the written request for confidential 

treatment that accompanies the comment must 

include the factual and legal basis for the request, 

and must identify the specific portions of the 

comment to be withheld from the public record. See 

FTC Rule 4.9(c), 16 CFR 4.9(c). 

the instructions on the web-based form. 

If you prefer to file your comment on 

paper, mail your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

600 Pennsylvania Avenue NW., Suite 

CC–5610 (Annex J), Washington, DC 

20580, or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW., 

5th Floor, Suite 5610 (Annex J), 

Washington, DC 20024. 

FOR FURTHER INFORMATION CONTACT: 

Requests for additional information 

should be addressed to Christine M. 

Todaro, Attorney, Division of Marketing 

Practices, Bureau of Consumer 

Protection, Federal Trade Commission, 

600 Pennsylvania Avenue NW., CC– 

8528, Washington, DC 20580, (202) 326– 

3711. 

SUPPLEMENTARY INFORMATION: On 

September 11, 2014, the FTC sought 

public comment on the information 

collection requirements associated with 

the Rule (September 11, 2014 Notice 1), 

16 CFR part 437 (OMB Control Number 

3084–0142). No comments were 

received. Pursuant to the OMB 

regulations, 5 CFR part 1320, that 

implement the PRA, 44 U.S.C. 3501 et 

seq., the FTC is providing this second 

opportunity for public comment while 

seeking OMB approval to renew the preexisting clearance for the Rule. All 

comments should be filed as prescribed 

herein, and must be received on or 

before January 8, 2015. 

Comments on the information 

collection requirements subject to 

review under the PRA should 

additionally be submitted to OMB. If 

sent by U.S. mail, they should be 

addressed to Office of Information and 

Regulatory Affairs, Office of 

Management and Budget, Attention: 

Desk Officer for the Federal Trade 

Commission, New Executive Office 

Building, Docket Library, Room 10102, 

725 17th Street NW., Washington, DC 

20503. Comments sent to OMB by U.S. 

postal mail, however, are subject to 

delays due to heightened security 

precautions. Thus, comments instead 

should be sent by facsimile to (202) 

395–5806. 

Burden statement: 

As detailed in the September 11, 2014 

Notice, the FTC estimates cumulative 

annual burden on affected entities to be 

10,065 hours, $2,516,250 in labor costs, 

and $3,062,139 in non-labor costs. 

Request for Comment: 

You can file a comment online or on 

paper. For the FTC to consider your 

comment, we must receive it on or 

before January 8, 2015. Write ‘‘Business 

Opportunity Rule Paperwork Comment, 

FTC File No. P114408’’ on your 

comment. Your comment—including 

your name and your state—will be 

placed on the public record of this 

proceeding, including, to the extent 

practicable, on the public Commission 

Web site, at http://www.ftc.gov/os/

publiccomments.shtm. As a matter of 

discretion, the Commission tries to 

remove individuals’ home contact 

information from comments before 

placing them on the Commission Web 

site. 

Because your comment will be made 

public, you are solely responsible for 

making sure that your comment does 

not include any sensitive personal 

information, like anyone’s Social 

Security number, date of birth, driver’s 

license number or other state 

identification number or foreign country 

equivalent, passport number, financial 

account number, or credit or debit card 

number. You are also solely responsible 

for making sure that your comment does 

not include any sensitive health 

information, like medical records or 

other individually identifiable health 

information. In addition, do not include 

any ‘‘[t]rade secret or any commercial or 

financial information which is obtained 

from any person and which is privileged 

or confidential . . . , ’’ as provided in 

Section 6(f) of the FTC Act, 15 U.S.C. 

46(f), and FTC Rule 4.10(a)(2), 16 CFR 

4.10(a)(2). If you want the Commission 

to give your comment confidential 

treatment, you must file it in paper 

form, with a request for confidential 

treatment, and you have to follow the 

procedure explained in FTC Rule 4.9(c), 

16 CFR 4.9(c).2 Your comment will be 

kept confidential only if the FTC 

General Counsel grants your request in 

accordance with the law and the public 

interest. 

Postal mail addressed to the 

Commission is subject to delay due to 

heightened security screening. As a 

result, we encourage you to submit your 

comments online, or to send them to the 

Commission by courier or overnight 

service. To make sure that the 

Commission considers your online 

comment, you must file it at https://

ftcpublic.commentworks.com/ftc/

BusinessOptionRulePRA2 by following 

the instructions on the web-based form. 

If this Notice appears at http://

www.regulations.gov/#!home, you also 

may file a comment through that Web 

site. 

If you file your comment on paper, 

write ‘‘Business Opportunity Rule 

Paperwork Comment, FTC File No. 

P114408’’ on your comment and on the 

envelope, and mail it to the following 

address: Federal Trade Commission, 

Office of the Secretary, 600 

Pennsylvania Avenue NW., Suite CC– 

5610 (Annex J), Washington, DC 20580, 

or deliver your comment to the 

following address: Federal Trade 

Commission, Office of the Secretary, 

Constitution Center, 400 7th Street SW., 

5th Floor, Suite 5610 (Annex J), 

Washington, DC 20024. If possible, 

submit your paper comment to the 

Commission by courier or overnight 

service. 

The FTC Act and other laws that the 

Commission administers permit the 

collection of public comments to 

consider and use in this proceeding as 

appropriate. The Commission will 

consider all timely and responsive 

public comments that it receives on or 

before January 8, 2015. For information 

on the Commission’s privacy policy, 

including routine uses permitted by the 

Privacy Act, see http://www.ftc.gov/ftc/ 

privacy.htm. For supporting 

documentation and other information 

underlying the PRA discussion in this 

Notice, see http://www.reginfo.gov/

public/jsp/PRA/praDashboard.jsp. 

David C. Shonka, 

Principal Deputy General Counsel. 

[FR Doc. 2014–28865 Filed 12–8–14; 8:45 am] 

BILLING CODE 6750–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

[Document Identifier: HHS–OS–0990–0390– 

60D] 

Agency Information Collection 

Activities; Proposed Collection; Public 

Comment Request 

AGENCY: Assistant Secretary of 

Administration, HHS. 

ACTION: Notice 

SUMMARY: In compliance with section 

3506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the Office of the 

Secretary (OS), Department of Health 

and Human Services, announces plans 

to submit an Information Collection 

Request (ICR), described below, to the 

Office of Management and Budget 

(OMB). The ICR is for revision of the 

approved information collection 

assigned OMB control number 0990– 


rljohnson on DSK3VPTVN1PROD with NOTICES
73076 Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices 

0390 which expires on February 28, 

2015. Prior to submitting that ICR to 

OMB, OS seeks comments from the 

public regarding the burden estimate, 

below, or any other aspect of the ICR. 

DATES: Comments on the ICR must be 

received on or before February 9, 2015. 

ADDRESSES: Submit your comments to 

Information.CollectionClearance@

hhs.gov or by calling (202) 690–6162. 

FOR FURTHER INFORMATION CONTACT: 

Information Collection Clearance staff, 

Information.CollectionClearance@

hhs.gov or (202) 690–6162. 

SUPPLEMENTARY INFORMATION: When 

submitting comments or requesting 

information, please include the 

document identifier HHS–OS0990– 

0390–60D for reference. 

Information Collection Request Title: 

Challenge and Prize Competition 

Solicitations. 

Abstract: In 2011, Federal agencies 

including HHS were given prize 

authority for administering challenges 

and competitions. Challenges and 

competitions enable the Assistant 

Secretary for Administration, HHS to 

tap into the expertise and creativity of 

the public in new ways. In order for 

HHS to quickly and effectively launch 

competitions on a continual basis, HHS 

seeks generic clearance to collect 

information for these challenges and 

competitions, which will generally 

include first name, last name, email, 

city, state and when applicable other 

demographic information. It can also 

include other information necessary to 

evaluate submissions and understand 

their impact related to the general goals 

of the competition. 

The information collected will be 

used to understand whether the 

participant has met the technical 

requirements for the challenge, assist in 

the technical review and judging of the 

solutions that are provided, and 

understand the impact and 

consequences of administering the 

competition and developing solutions 

for submission. Information may be 

collected during the competition or after 

its completion. 

Need and Proposed Use of the 

Information: In 2011, Federal agencies 

including HHS were given prize 

authority for administering challenges 

and competitions. Section 105(a) of the 

America Competes Act, adds Section 24 

to the Stevenson-Wydler Technology 

Innovation Act of 1980 (15 U.S.C. 3701 

et seq.) that addresses provisions for 

challenges and competitions with prizes 

conducted by Federal agencies. 

Challenges and competitions enable 

HHS to tap into the expertise and 

creativity of the public in new ways. 

HHS has sponsored challenges and 

competitions in a wide variety of areas 

such as recruitment efforts, health data 

applications and other types of data, 

development of novel technologies, and 

communications to increase public 

participation and solicit new ideas on a 

wide array of topics important to the 

agencies mission. HHS’s goal is to 

engage a broader number of 

stakeholders who are inspired to work 

on some of our most pressing health 

issues, thus supporting a new ecosystem 

of scientists, developers, and 

entrepreneurs who can continue to 

innovate for public health. 

The generic clearance is necessary for 

HHS to quickly and effectively launch 

competitions on a continual basis. The 

information collected for these 

challenges and competitions will 

generally include first name, last name, 

email, city, state and when applicable 

other demographic information. It can 

also include other information 

necessary to evaluate submissions and 

understand their impact related to the 

general goals of the competition. Upon 

entry or during the judging process, 

applicants under the age of 18 may be 

asked to confirm parental consent, 

requiring students under 18 to have a 

parent signature in writing on a parental 

consent form provided by the 

Department in order to qualify for the 

contest. For certain challenges we may 

also need to collect data such as types 

of data sets used in the solution, types 

of software tools used in the solution, 

and information regarding uses of 

proprietary software (i.e., licenses or use 

agreements). Information obtained from 

participants will be used by the program 

managers (challenge manager), other 

agency officials (such as general counsel 

representatives) and in some cases the 

technical reviewers acting on behalf of 

the program manager (challenge 

manager). The information collected 

will be used to understand whether the 

participant has met the technical 

requirements for the challenge, assist in 

the technical review and judging of the 

solutions that are provided, and 

understand the impact and 

consequences of administering the 

competition and developing solutions 

for submission. Information may be 

collected during the competition or after 

its completion. 

To obtain approval for a collection 

under this generic, HHS will provide a 

copy of the Federal Register notice used 

for the challenge, a standardized form 

that includes an estimate of the burden, 

and the instrument (e.g., a 

questionnaire) to OMB. 

Likely Respondents: Likely 

respondents include individuals, 

businesses, and state and local 

governments who choose to participate 

in a challenge or competition hosted by 

HHS. 

TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS

Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response (in 

hours) 

Total burden 

hours 

Individuals or Households ............................................................................... 1000 1 1/6 166.6 

Organizations ................................................................................................... 1000 1 1/6 166.6 

Businesses ....................................................................................................... 1000 1 1/6 166.6 

State, territory, tribal or local governments ..................................................... 60 1 1/6 10 

Total .......................................................................................................... 3060 ........................ ........................ 510 

OS specifically requests comments on 

(1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 


rljohnson on DSK3VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 236 / Tuesday, December 9, 2014 / Notices 73077 

Darius Taylor, 

Information Collection Clearance Officer. 

[FR Doc. 2014–28705 Filed 12–8–14; 8:45 am] 

BILLING CODE 4150–04–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Findings of Misconduct in Science 

AGENCY: Office of the Secretary, HHS. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that 

the Office of Research Integrity (ORI) 

has taken final action in the following 

case: 

Kaushik Deb, Ph.D., University of 

Missouri-Columbia: Based upon the 

evidence and findings of an 

investigation report by the University of 

Missouri-Columbia (UM) transmitted to 

the United States Department of Health 

and Human Services (HHS), Office of 

Research Integrity (ORI) and additional 

analysis conducted by ORI in its 

oversight review, ORI found that Dr. 

Kaushik Deb, former Postdoctoral 

Fellow, Life Sciences Center, UM, 

engaged in misconduct in science in 

research that was supported by National 

Institute of Child Health and Human 

Development (NICHD), National 

Institutes of Health (NIH), grants 2 R01 

HD021896 and 5 R01 HD042201–05 and 

National Center for Research Resources 

(NCRR), NIH, grant 5 R01 RR013438–07. 

ORI found that the Respondent 

intentionally, knowingly, and recklessly 

fabricated and falsified data reported in 

the following published paper: 

• Deb, K., Sivarguru, M., Yong, H., & 

Roberts, R.M. ‘‘Cdx2 gene expression 

and trophectoderm lineage specification 

in mouse embryos.’’ Science 311:992– 

996, 2006 (hereafter referred to as 

‘‘Science 311’’); this paper was retracted 

on July 27, 2007 

An earlier version of Science 311 had 

been previously submitted to Nature on 

or about June 24, 2005 (hereafter 

referred to as ‘‘Nature #1’’). It was 

revised and resubmitted to Nature on or 

about August 24, 2005, and ultimately 

was rejected by Nature on September 

14, 2005 (hereafter referred to as 

‘‘Nature #2’’). 

Specifically, ORI finds by a 

preponderance of the evidence that the 

Respondent engaged in misconduct in 

science by intentionally, knowingly, 

and recklessly: 

1. Falsifying and/or fabricating three 

panels of data in Figure 1 (Figures 1C, 

1D, and 1E) in Science 311 and in 

Nature #1 and Nature #2, by photomanipulating confocal fluorescent 

images to falsely represent three-, 

four-, and six-cell embryos, thereby 

supporting the paper’s central premise 

that cells derived from a late-dividing 

blastomere would be positive for a 

transcription factor, Cdx2, while the 

cells derived from a leading blastomere 

would be Cdx2 negative 

2. using photo-manipulation to falsify 

and fabricate at least 13 panels of 

confocal image data in Figures 2, 3, and 

S2, including Figures 2K, 2L, 2Q, 2R, 

2V, 2X, 3G, 3H, 3I, S2s, S2t, S2u, and 

2W, in Science 311 and in 

corresponding figures in Nature #1 and 

Nature #2 so that these images falsely 

supported the central premise in 

Science 311 that Cdx2-expressing cells 

were peripherally located in the embryo 

3. falsifying Figures 2G, 3J, 3L, S2V, 

S2X, S6I, S6J, and S6K in Science 311, 

Figures 2A, 2C, S4v, and S4x in Nature 

#1, and Figures 2G, 3I, 3J, and 3K in 

Nature #2 by reusing and re-labelling 

the same image to represent different 

embryos and different experimental 

conditions 

4. falsifying Figure 4 in Science 311 

and corresponding figures submitted in 

Nature #1 and Nature #2 to falsely 

illustrate that the first dividing cell of a 

two-cell mouse embryo will ultimately 

differentiate into the trophoblast; 

specifically, Respondent: 

• Falsely colored and 

photomanipulated a single bright-phase 

image of a three-cell embryo to make it 

appear as four separate embryos that 

had been differentially injected with 

TRD 

• falsely colored and 

photomanipulated a four-cell embryo to 

make TRD appear distinctly located in 

the lagging cell and in its descendent 

cell, when the actual embryo contained 

diffuse staining within the sub-zonal, 

extracellular space 

• photomanipulated a damaged, nonviable two-cell embryo to make it 

appear viable 

• re-used, falsely colored, and 

relabeled seven images from an 

unrelated experiment to falsely 

represent a time lapse course of eight 

different images 

5. falsifying Figures 5K, 5L, 5N, and 

5O in Science 311 by photomanipulating a single confocal image to 

falsely represent four different images at 

two different stages of embryonic 

development. The images also were 

presented as Figures 4k, 4l, 4n, and 4o 

in Nature #1. 

The Respondent failed to take 

responsibility for the fabrication and 

falsification described in ORI’s findings. 

The following administrative actions 

have been implemented for a period of 

three (3) years, beginning on November 

17, 2014: 

(1) Respondent is debarred from any 

contracting or subcontracting with any 

agency of the United States Government 

and from eligibility for, or involvement 

in, nonprocurement programs of the 

United States Government referred to as 

‘‘covered transactions’’ pursuant to 

HHS’ Implementation (2 CFR part 376 et 

seq) of Office of Management and 

Budget (OMB) Guidelines to Agencies 

on Governmentwide Debarment and 

Suspension, 2 CFR part 180 (collectively 

the ‘‘Debarment Regulations’’); and 

(2) Respondent is prohibited from 

serving in any advisory capacity to PHS 

including, but not limited to, service on 

any PHS advisory committee, board, 

and/or peer review committee, or as a 

consultant. 

FOR FURTHER INFORMATION: Acting 

Director, Office of Research Integrity, 

1101 Wootton Parkway, Suite 750, 

Rockville, MD 20852, (240) 453–8800. 

Donald Wright, 

Acting Director, Office of Research Integrity. 

[FR Doc. 2014–28859 Filed 12–8–14; 8:45 am] 

BILLING CODE 4150–31–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Submission for OMB Review; 

Comment Request 

Title: Head Start Family and Child 

Experiences Survey (FACES). 

OMB No.: 0970–0151. 

Description: The Office of Planning, 

Research and Evaluation (OPRE), 

Administration for Children and 

Families (ACF), U.S. Department of 

Health and Human Services (HHS), is 

proposing to collect data for a new 

round of the Head Start Family and 

Child Experiences Survey (FACES). 

Featuring a new ‘‘Core Plus’’ study 

design, FACES will provide data on a 

set of key indicators, including 

information for performance measures. 

The design allows for more rapid and 

frequent data reporting (Core studies) 

and serves as a vehicle for studying 

more complex issues and topics in 

greater detail and with increased 

efficiency (Plus studies). 


rljohnson on DSK3VPTVN1PROD with NOTICES